Teva Pharmaceuticals has received approval to manufacture a new drug to combat high cholesterol.
Following the announcement Sunday, Teva stock soared by 4.5 percent, and economists estimate that the drug could sell for some five billion dollars a year.
The drug, Simvastatin, was approved by the FDA on Thursday. It was originally developed by the American pharmaceuticals manufacturer Ivax, which Teva acquired in January, Army Radio reported.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>